Go Pro
NASDAQ:DCGO

DocGo (DCGO) Stock Price, News & Analysis

DocGo logo
$0.66 +0.01 (+1.35%)
As of 02:31 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About DocGo Stock (NASDAQ:DCGO)

Advanced

Key Stats

Today's Range
$0.64
$0.67
50-Day Range
$0.46
$0.67
52-Week Range
$0.45
$1.73
Volume
163,398 shs
Average Volume
862,443 shs
Market Capitalization
$65.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.38
Consensus Rating
Hold

Company Overview

DocGo, Inc. is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging. The company also partners with public health agencies, employers, universities and event organizers to administer diagnostic testing services for COVID-19 and other infectious diseases. By integrating telehealth, remote patient monitoring and mobile diagnostic capabilities, DocGo aims to streamline access to care, reduce strain on traditional facilities and improve patient outcomes.

DocGo became a publicly traded company in June 2021 following a business combination with SPAC sponsor GigCapital3 Inc., trading on the Nasdaq under the ticker DCGO. Headquartered in Austin, Texas, the company has expanded its reach across multiple U.S. markets, including metropolitan areas in California, Florida, Texas and New York. DocGo’s on-demand approach leverages technology and logistics to enhance convenience, affordability and quality of care for both urban and rural communities.

AI Generated. May Contain Errors.

DocGo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

DCGO MarketRank™: 

DocGo scored higher than 62% of companies evaluated by MarketBeat, and ranked 340th out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DocGo has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 3 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    DocGo has a consensus price target of $2.38, representing about 263.1% upside from its current price of $0.65.

  • Amount of Analyst Coverage

    DocGo has only been the subject of 1 research reports in the past 90 days.

  • Read more about DocGo's stock forecast and price target.
  • Earnings Growth

    Earnings for DocGo are expected to grow in the coming year, from ($0.12) to $0.05 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DocGo is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DocGo is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DocGo has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about DocGo's valuation and earnings.
  • Percentage of Shares Shorted

    2.60% of the float of DocGo has been sold short.
  • Short Interest Ratio / Days to Cover

    DocGo has a short interest ratio ("days to cover") of 5.27.
  • Change versus previous month

    Short interest in DocGo has recently increased by 5.49%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    DocGo does not currently pay a dividend.

  • Dividend Growth

    DocGo does not have a long track record of dividend growth.

  • News Sentiment

    DocGo has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for DocGo this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for DCGO on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added DocGo to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DocGo insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    5.10% of the stock of DocGo is held by insiders.

  • Percentage Held by Institutions

    56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about DocGo's insider trading history.
Receive DCGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DCGO Stock News Headlines

Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
DocGo delays quarterly SEC filing briefly
DocGo Inc.
DocGo Extends $26 Million Share Repurchase Program
See More Headlines

DCGO Stock Analysis - Frequently Asked Questions

DocGo's stock was trading at $0.8778 at the beginning of the year. Since then, DCGO stock has decreased by 25.5% and is now trading at $0.6540.

DocGo Inc. (NASDAQ:DCGO) posted its earnings results on Monday, May, 11th. The company reported ($0.12) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.10. The firm earned $75.55 million during the quarter, compared to the consensus estimate of $72.48 million. DocGo had a negative net margin of 62.23% and a negative trailing twelve-month return on equity of 44.09%.
Read the conference call transcript
.

DocGo's top institutional shareholders include S Squared Technology LLC (2.08%), BlackRock Inc. (1.47%), GSA Capital Partners LLP (1.01%) and Marquette Asset Management LLC (0.34%). Insiders that own company stock include Lee Bienstock, Adriaan Stephanus Oberholzer, Anthony Capone, Stephen Sugrue, Ely D Tendler and Stephen K MD Klasko.
View institutional ownership trends
.

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), Adobe (ADBE), Broadcom (AVGO), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
5/11/2026
Today
8/14/2026
Next Earnings (Confirmed)
8/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:DCGO
CIK
1822359
Fax
N/A
Employees
3,568
Year Founded
N/A

Price Target and Rating

High Price Target
$3.00
Low Price Target
$1.00
Potential Upside/Downside
+258.8%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$182.40 million
Net Margins
-62.23%
Pretax Margin
-62.77%
Return on Equity
-44.09%
Return on Assets
-29.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.79
Quick Ratio
1.79

Sales & Book Value

Annual Sales
$322.20 million
Price / Sales
0.20
Cash Flow
$0.05 per share
Price / Cash Flow
12.10
Book Value
$1.28 per share
Price / Book
0.52

Miscellaneous

Outstanding Shares
98,750,000
Free Float
93,714,000
Market Cap
$65.37 million
Optionable
Optionable
Beta
0.99
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:DCGO) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners